Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 3/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.32 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12455986 | 1.00 | PGR (0.33) | PGRPDK2HSD11B1PTGES2PDE10A | |
| SCHEMBL10001383 | 0.98 | PGR (0.34) | PGRPDK2HSD11B1PTGES2PDE10A | |
| SCHEMBL15946293 | 0.97 | KDM4E (0.35) | PGRPDK2HSD11B1PDE10AATM | |
| SCHEMBL15946301 | 0.96 | KDM4E (0.38) | PGRPDK2PDE10AATM | |
| SCHEMBL18518997 | 0.95 | PGR (0.33) | PGRPDK2ATM | |
| SCHEMBL17229932 | 0.95 | PDK2 (0.33) | PGRPDK2PTGES2 | |
| SCHEMBL20408495 | 0.95 | PGR (0.34) | PGRPDK2PTGES2ATM | |
| SCHEMBL14822427 | 0.94 | PGR (0.32) | PGRPDK2ATM | |
| SCHEMBL14822512 | 0.94 | KDM4E (0.37) | PGRPDK2PDE10AUSP2CYP2C9 | |
| SCHEMBL15946289 | 0.94 | PDK2 (0.32) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3323159-B1 | COMPOSITION COMPRISING ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2023-01-04 | — | — | EP | disclosed |
| US-10714691-B2 | Formulations for the production of electronic devices | MERCK PATENT GMBH (DE) | 2020-07-14 | — | — | US | disclosed |
| US-20190207114-A9 | FORMULATIONS AND ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2019-07-04 | — | — | US | disclosed |
| EP-2477999-B1 | FORMULATIONS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2019-01-23 | — | — | EP | disclosed |
| US-20180212166-A1 | COMPOSITION COMPRISING ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2018-07-26 | — | — | US | disclosed |
| US-20180212166-A1 | COMPOSITION COMPRISING ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2018-07-26 | — | — | US | disclosed |
| US-20180114912-A1 | FORMULATIONS AND ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2018-04-26 | — | — | US | disclosed |
| US-20180114912-A1 | FORMULATIONS AND ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2018-04-26 | — | — | US | disclosed |
| US-9882135-B2 | Formulations and electronic devices | MERCK PATENT GMBH (DE) | 2018-01-30 | — | — | US | disclosed |
| US-9882135-B2 | Formulations and electronic devices | MERCK PATENT GMBH (DE) | 2018-01-30 | — | — | US | disclosed |
| US-8974702-B2 | Composition for the preparation of organic electronic (OE) devices | MERCK PATENT GMBH (DE) | 2015-03-10 | — | — | US | disclosed |
| WO-2015018480-A1 | FORMULATION FOR THE PREPARATION OF ORGANIC ELECTRONIC (OE) DEVICES COMPRISING A POLYMERIC BINDER | MERCK PATENT GMBH (DE) | 2015-02-12 | — | — | WO | disclosed |
| US-20140048745-A1 | FORMULATIONS AND ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2014-02-20 | — | — | US | disclosed |
| US-20140048745-A1 | FORMULATIONS AND ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2014-02-20 | — | — | US | disclosed |
| US-20130062581-A1 | COMPOSITION FOR THE PREPARATION OF ORGANIC ELECTRONIC (OE) DEVICES | MERCK PATENT GMBH (DE) | 2013-03-14 | — | — | US | disclosed |
| US-20130062581-A1 | COMPOSITION FOR THE PREPARATION OF ORGANIC ELECTRONIC (OE) DEVICES | MERCK PATENT GMBH (DE) | 2013-03-14 | — | — | US | disclosed |
| US-20120238105-A1 | FORMULATIONS FOR THE PRODUCTION OF ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-09-20 | — | — | US | disclosed |
| US-20120238105-A1 | FORMULATIONS FOR THE PRODUCTION OF ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2012-09-20 | — | — | US | disclosed |
| WO-2011137922-A1 | FORMULATIONS AND ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2011-11-10 | — | — | WO | disclosed |
| WO-2011076380-A1 | COMPOSITION FOR THE PREPARATION OF ORGANIC ELECTRONIC (OE) DEVICES | MERCK PATENT GMBH (DE) | 2011-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238105-A1 | FORMULATIONS FOR THE PRODUCTION OF ELECTRONIC DEVICES | NR3C2, KCNE1, KCNJ2 | PGR 2502/4885PDK2 3182/4885HSD11B1 529/4885 |
| US-20180114912-A1 | FORMULATIONS AND ELECTRONIC DEVICES | SLC19A1, IK, KCNQ2 | PGR 2017/4885PDK2 1498/4885HSD11B1 2335/4885 |
| US-20190207114-A9 | FORMULATIONS AND ELECTRONIC DEVICES | SLC19A1, IK, KCNQ2 | PGR 2017/4885PDK2 1498/4885HSD11B1 2335/4885 |
| US-10714691-B2 | Formulations for the production of electronic devices | NR3C2, KCNE1, NR2E1 | PGR 2428/4885PDK2 3261/4885HSD11B1 524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.